Why I Voted 'No' on the New ALS Drug

13. October 2022 Health 0
Why I Voted 'No' on the New ALS Drug
(MedPage Today) — In March and September 2022, I served on an FDA Advisory Committee reviewing the application of Amylyx Pharmaceuticals for the novel drug AMX0035 for patients with amyotrophic lateral sclerosis (ALS). I voted against approval… Powered by WPeMatico